In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis-Reference-Cited by-同舟云学术

In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis

Published:1996-10 Issue:10 Volume:40 Page:2428-2430
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Mulazimoglu L¹,Drenning S D¹,Yu V L¹

Affiliation:

1. Section of Infectious Diseases, Marmara University School of Medicine, Istanbul, Turkey.

Abstract

Two oxazolidinones (U100592 and U100766), trovafloxacin, and a streptogramin combination (dalfopristin-quinupristin) were highly active in vitro against Staphylococcus aureus and Staphylococcus epidermidis, including methicillin-resistant strains. Trovafloxacin was more active than ciprofloxacin. Time-kill synergy studies demonstrated indifference for the oxazolidinones combined with vancomycin and rifampin against methicillin-resistant staphylococci. Spontaneous resistance was observed with all agents.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.40.10.2428

Reference8 articles.

1. In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms;Collins L. A.;Antimicrob. Agents Chemother.,1993

2. Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds;Daly J. S.;J. Antimicrob. Chemother.,1988

3. Eliopoulos G. M. and R. C. Moellering Jr. 1991. Antimicrobial combinations p. 432-492. In V. Lorian (ed.) Antibiotics in laboratory medicine 3rd ed. Williams & Wilkins Baltimore.

4. Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620;Hirschhorn L.;Antimicrob. Agents Chemother.,1986

5. Communityacquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical;Levine D. P.;Center. Ann. Intern. Med.,1982

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A case of community-acquired Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus (MRSA) necrotizing pneumonia successfully treated with two anti-MRSA drugs;Respiratory Medicine Case Reports;2024

2. Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections;Seminars in Respiratory and Critical Care Medicine;2015-02-02

3. Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus;Current Topics in Microbiology and Immunology;2015

4. Rifampin Combination Therapy for Nonmycobacterial Infections;Clinical Microbiology Reviews;2010-01

5. İn Vitro Activity of Linezolid in Combination with Vancomycin, Teicoplanin, Fusidic Acid, and Ciprofloxacin Against Gram-Positive Pathogens;Turkiye Klinikleri Journal of Medical Sciences;2010